MATTERHORN: FLOT plus durvalumab leads to high pCR rate in gastric cancer Presented ByDr Yelena Janjigian, Memorial Sloan Kettering Cancer Center, NY, USA TrialPhase 3, MATTERHORN ConferenceASCO GI 2024 13 February, 2024 14:19